Study to evaluate accuracy of Early detection method for various cancer types for both the genders
Not Applicable
Completed
- Conditions
- Health Condition 1: R978- Other abnormal tumor markers
- Registration Number
- CTRI/2023/03/050316
- Lead Sponsor
- Dr Imliwati Longkumer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 2700
Inclusion Criteria
1. Cancer patients within the age group of 18 to 75 yrs
2. Individuals who have been diagnosed for any of the Cancer types
Exclusion Criteria
1. Individuals with no known cancer, high-grade dysplasia, autoimmune disease, or
chronic kidney disease.
2. Cancer patients who have received any kind of Immuno / chemo / radiation /
medical / etc. therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Validate the established screening methodology from single sample to identify/ <br/ ><br>isolate known unknown cancer types and assist in early detection, treatment.Timepoint: Screening <br/ ><br>Day 7
- Secondary Outcome Measures
Name Time Method Validation of existing AI algorithm to ensure specificity, sensitivity and precision.Timepoint: Screening <br/ ><br>Day 7